CAMBRIDGE, Mass. & SALISBURY, England, February 04, 2025--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback